Q32 Bio (QTTB) Revenue (2018 - 2023)
Q32 Bio's (QTTB) quarterly Revenue came in at -$1.4 million in Q4 2023, down 269.58% year-on-year from $802000.0 in Q4 2022, and down 173.16% quarter-over-quarter from $1.9 million in Q3 2023.
Q32 Bio (QTTB) Revenue (2018 - 2023) Analysis & Trends
Q32 Bio's Revenue history runs 6 years deep, the most recent figure standing at -$1.4 million for Q4 2023.
- On a quarterly basis, Revenue fell 269.58% year-over-year to -$1.4 million in Q4 2023; TTM through Sep 2024 was -$1.4 million, a 115.43% decrease from a year earlier, with the FY2025 full-year figure at $53.7 million, changed N/A from the prior year.
- Revenue fell to -$1.4 million in Q4 2023 per QTTB's latest filing, from $1.9 million in the prior quarter.
- Across five years, Revenue topped out at $29.3 million in Q1 2021 and bottomed at -$1.4 million in Q4 2023.
- The 5-year median for Revenue is $802000.0 (2021), against an average of $2.4 million.
- Across the five-year window, Revenue soared 4883.84% in 2021 and slumped 269.58% in 2023, its largest moves.
- Year by year, Revenue stood at $563000.0 in 2019, then soared by 74.07% to $980000.0 in 2020, then dropped by 18.16% to $802000.0 in 2021, then changed by 0.0% to $802000.0 in 2022, then slumped by 269.58% to -$1.4 million in 2023.
- Per Business Quant, the three latest QTTB Revenue figures stand at -$1.4 million (Q4 2023), $1.9 million (Q3 2023), and $3.2 million (Q2 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Q32 Bio | 213.90 Mn | 163.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.36 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 802,000.00 |
| Sep 30, 2022 | 802,000.00 |
| Jun 30, 2022 | 802,000.00 |
| Mar 31, 2022 | 802,000.00 |
| Dec 31, 2021 | 802,000.00 |
| Sep 30, 2021 | 1.68 Mn |
| Jun 30, 2021 | 2.19 Mn |
| Mar 31, 2021 | 29.31 Mn |
| Dec 31, 2020 | 980,000.00 |
| Sep 30, 2020 | 567,000.00 |
| Jun 30, 2020 | 567,000.00 |
| Mar 31, 2020 | 588,000.00 |
| Dec 31, 2019 | 563,000.00 |
| Sep 30, 2019 | 441,000.00 |
| Jun 30, 2019 | 392,000.00 |
| Mar 31, 2019 | 270,000.00 |